3.radiation Inj

Download as doc, pdf, or txt
Download as doc, pdf, or txt
You are on page 1of 9

Surgery

Dr. Faruq Lec: -3-


17-Oct-06

Radiation inj.of intestine


• Radiation Therapy-a component of multimodality therapy for many intra-
abdominal & pelvic cancers,such as those of cervix, endomertrium, ovary,
bladder, prostate &rectum.
• An undesired S.E of radiation therapy is radiation inj. To intestine, which can
present as 2 distinct syndromes;
• 1-Acute radiation enteritis
• Chronic radiation enteritis.

Acute radiation enteritis

• Transient condition
• Occurs in approximately 75% of patients.
• Main effects on mucosa
• Radiation induces cellular inj directly & via the generation of free radicals.
• Clinical presentations; nausea,vomiting,diarrhea & crampy abd. Pain.
• Dx. Obvious, & the condition is transient

Chronic Radiation enteritis(CRE)

• Inexorable.
• Develops in approximately 5-15 % .
• There is a progressive occlusive vasculitis---that leads to chronic ischemia &
fibrosis, that affects all layers of intestinal wall--- these changes ---strictures,
abscesses & fistula formation.

CRE( Presentations)
• Usually become evident within 2 years.
• Terminal ileum most commonly affected.
• Partial small bowel obstruction-Nausea ,vomiting,intermittent abd.
Distension, crampy abd. Pain & wt loss.
• Complete bowel obstrcution.
• Acute or ch. Intestinal haemorrhage.
• Abscess or fistula formation.

1
CRE( Dx)
• Enteroclysis-contrast radiograph of small intestine:1-widely separated loops of
small bowel.2- luminal narrowing.3-loss of mucosal folds.4-ulcerations.
• CT scan to exclude recurrent cancer.

Rx
• Acute RE- self limited. Supportive Rx
• CRE-Surgery- very difficult with high M&M.( M.R=10%)
• Surgery indicated for;high grade obstruction. Haemorrhage.Intra-abd. Abscess
& fistulas.
• Limited resection + anatamosis

Intestinal Fistulas
(Epidemiology)
• Definition- a fistula- abnormal communication bet.2 epithelialized surface.
• Internal fistulas- communications bet.2 parts of GIT( enterocolic F.), or bet.
GIT a & adjacent organ ( colovesicular F).
• External F.( enterocutaneous F., or rectovaginal F.)involves the skin or another
ext.surface epithelium.
• Low-output F-drains <500ml/d.
• High-output F- drains >500ml /d
• 80% iatrogenic inj.( complications), as a result of enterotomies or intestinal
anastamotic dehisence.
• Spontaneous F—Crohn’s dis, Cancer,CRE

Aetiology
A- Congenital –patent vitello-intestinal duct

B-acquired- most common causes are:


• 1-anastomotic leakage
• 2-inflam. Bowel disease
• 3-malignancy
• 4-radiotherapy
• 5-trauma

2
Pathophysiology
• Enteroenteric F-››››malabsorption syndrome.
• Enterovesical F- Recurrent UTI
• Enterocutaneous F– skin excoraition.
• High-output F.—dehydration, electrolyte abnormalities & malnutrition
• Fistulas have the potential to close spontaneously.
• Factors inhibiting spontaneous closure are:malnutrition,sepsis, Inflam. Bowel
dis, cancer,radiation, distal obstruction, F.B,high-output, & epithelialization of
fistula

Clinical presentations

• Iatrogenic enterocutaneous F. clinically evident bet 5th & 10th postoperative


days.
• Initial signs :.
Fever. Leukocytosis. Prolonged ileus, abdominal tenderness & wound infection
• Dx- becomes obvious,when drainage of enteric material viaabd. Wound or
existing drains occur. These fistulas are often ass. With intra-abd. Abscesses.

Dx
• Enhanced CT scan
• Small bowel series- enteroclysis
• Fistulogram

Rx

Step 1(Stabilization)

• Fluid & electrolyte resuscitation.


• Nutrition, usually parentral route initially.
• Sepsis is controlled- Ab, localisation & drainage.
• Skin- care & protection with ostomy appliances or fitula drains.

3
Step 2 ( Investigation)

Definition of anatomy
• Anatomy of fistula is defined using:
• CT scan
• Small bowel series
• Fistulogram

Step 3(Rehabilitation)
Carrying out the definitive procedure
(where necessary)
• Probability of spontaneous closure is maximized.
• Nutrition & time are the key components
• Most patients will require TPN, however, a trial of oral or entral nutrition
should be attempt in low-output fistulas, originating from distal ileum.
• Octreotide- somatotatin analogue;reduces the volume of fistula output & may
accelerate the rate of closure.
• 2 to 3 months are allowed for spontaneous closure, after that they are unlikely
to do so.
• Surgery-remove of fisltua tract + the involved segment of bowel from which
the fistula originated

OUTCOME

• M.R- 10-15 %- mostly related to sepsis or underlying disease.


• Overall 50% close spontaneously
• FRIEND- a useful mnemonic designates factors that inhibit spontaneous
closure
• F.B. Radiation enteritis. Infection/inflammation at the fistula
origin.Epithelialization of the fistula tract.Neoplasm at the fistula origin.Distal
obstruction of the intestine.
• Surgery for fistulas is associated with >50%MR, including a 10 % recurrence
rate.

4
Mesenteric ischemia
1-Acute.Causes

• 1-Arterial embolus-
• 2-arteial thrombosis
• 3-Vasospasm( also known as ;nonocclusive mesenteric ischemia, or NOMI)
• 4-venous thrombosis

Art.Embolism
• Most common cause of art.Emb.>50% of cases
• Source of Emboli- usually-Heart.95% LA,or ventricular or valvular lesions.
• SMA- embolism 50% of cases.

Art.thrombosis
• Usually superimposed on pre-existing atherosclerotic lesions

NOMI
The result of vasospasm & usually diagnosed in critically –ill-patients who are
receiving vasopressor agents

Mesenteric venous thrombosis

• Accounts for 5-15% of cases of acute mesenteric ischemia.


• Involves the SM vein in 95% of cases.
• IMV- only rarely involved.
• Classified as primary-if no etilogic factor is identifiable, or as sec.if an etilogic
factor, such as heritable or acquired coagulation disorders, is identified

Regardless of the cause:


Acute mesenteric ischemia can---
• Intestinal mucosal sloughing within 3 hours of onset
• Full- thickness intestinal infarction by 6 hours.

5
2-Chronic mesenteric ischemia
• Develops insidiously, allowing for development of collat. Circulation.
• Rarely leads to intestinal infarction
• Ch.mesent. Art. Ischemia- from atherosclerosis in the main splanchnic
art.s(caeliac, SMA, IMA)
• Chronic form of mesenteric venous thrombosis can involve the portal or
splenic veins—portal HT

Clinical presentation
• The hallmark of acute Mesent. Isch is :Severe abd. Pain out of proportion to
the degree of tenderness O/E .
• The pain – colicky & most severe in the mid-abd
• Associated symptoms can include; nausea,vomiting & diarrhea.
• Physical exam.- characteristically absent early in the course of ischemia.
• With onset of bowel infarction;abd. Distension, peritonitis &passage of bloody
stools occur

Presentation
( Chronic mesent. Isch)

• -presents insidiously.
• Postprandial abd. Pain- the most prevalent symptom, producing a
characteristic aversion to food (food-fear) & wt. loss.
• Often thought to have malignancy & suffer a prolonged period of symptoms
before the correct Dx is made.

(Ch. Mesent. Venous thrombosis)


• Mostly asymptomatic bec. Of collat.
• Usually discovered as an incidental finding on imaging studies.
• Some patients- present with bleeding from esophagogastric varices

6
Dx

• Lab.tests abnormalities, such as leukocytosis,acidosis, Increase in amylase are


late findings.
• Patients suspected of having acute mesent. Ischemia & who have physical
findings suggestive of peritonitis should undergo emergent laparotomy
• CT Scanning- sensitive in 64-82% . If negative & the case suspicious Do
angio
• Angiography-sensitivity of 74-100% & specificities approaching 100%
• Angiography- is invasive, time-consuming & costly

Rx(imp. Considerations in selecting Rx options)


• The presence or absence of signs of peritonitis
• The presence or absence of ischemic but viable intestine
• The general condition of the patient
• The specific vascular lesions lesion causing mesenteric ischemia

Signs of peritonitis -detected


• Emergent laparotomy .
• Assess the viability of bowel
• Resection& anastamosis
• Sec look laparotomy

Embolus or thrombus-induced ischemia


• 1-Standard Rx-surgical revascularization:
• Embolectomy
• Thrombectomy
• Mesenteric bypass
• B- C.I to these op. are:
• 1-if most bowel supplied by the affected art. Infarcted 2-unstable patients

Chronic radiation inj of the intestine


(Epidemiology)

• May occur in any patient who has radioRx to the abdomen or pelvis.
• Most patients –young or middle –aged women treated for pelvic malign.
• Occurs in elderly men with ca. prostate.
• Occurs in adolescents treated for testicular tumors

7
Aetiology

• The intestine is radiosensitive , particularly the small intestine with its rapid
mucosal cell turnover cycle.
• Inj- directly related to total radiation dose
• Possible factors – previous abd. Op.
previous pelvic sepsis
Atherosclerosis
D.M
Concomitant chemoRx

Pathology
• Progressive ischemia- any part, usually the distal ileum & rectosigmoid region
• Gross-appearance- bowel –white ,telangectasia, thickened,indurated &
narrowed. adhesion, fistulas to vagina, bladder, or other loops of bowel
• Microscopic-thickening of submucosa by fibrosis.Obliterative vasculitis in
arterioles & venules. Infiltration of the bowel wall with lymphocytes & bizarre
fibroblasts

Clinical features

Essential to the Dx-is past Hy of irradiation, therapeutic or otherwise.


1-Strictures—Partial I.O-symptoms—intermittent.
2-Necrosis---free perforation or fistulas
3-Ulceration-may cause haemorrhage
4-Malabsorption-wt loss
5-Urinary symptoms-freq.,dysuria or hematuria-(radiation cystitis).
6-Defecatory symptoms-loss of compliance of rectum-urgency, frq, & tenesmus

NOMI
• Standard Rx-infusion of vasodilator
• papaverine

8
Acute mesenteric venous thrombosis
• Standard Rx- Anticoagulation
• Heparin

Outcome
• MR- acute art.mesenteric isch—59-93%
• MR- mesenteric venous thrombosis-20-50%
• MR- of surgery-0-16%
• Recurrent rate after surgery < 10%

Prepared by:
Rand Aras Najeeb

You might also like